Gabriel N Waterman
Overview
Explore the profile of Gabriel N Waterman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez E, Tanenbaum E, Patil S, Li M, Soof C, Vidisheva A, et al.
Expert Rev Mol Diagn
. 2018 Mar;
18(4):319-329.
PMID: 29504446
B-cell maturation antigen (BCMA) is a cell membrane bound tumor necrosis factor receptor family member that is expressed exclusively on late stage normal and malignant B-cells and plasma cells. Addition...
2.
Robinson A, Wang J, Vardanyan S, Madden E, Hebroni F, Udd K, et al.
Eur J Haematol
. 2016 Feb;
97(5):439-444.
PMID: 26872804
Immunosuppressed patients are known to have an increased incidence of skin cancer. Patients with multiple myeloma (MM) show impaired immune function. In the past, because of poor survival, the incidence...
3.
Sanchez E, Li M, Kitto A, Li J, Wang C, Kirk D, et al.
Br J Haematol
. 2012 Jul;
158(6):727-38.
PMID: 22804669
Although TNFRSF17 (also designated as B-cell maturation antigen (BCMA)) is expressed on tumour cells in B-cell malignancies, it has not been found in serum. The present study found that BCMA...
4.
Waterman G, Yellin O, Jamshidinia K, Swift R, Tamkin J, Audell R, et al.
J Bone Joint Surg Am
. 2011 Sep;
93(18):e106.
PMID: 21938357
No abstract available.
5.
Waterman G, Yellin O, Swift R, Mapes R, Eades B, Ackerman E, et al.
Ann Hematol
. 2010 Sep;
90(2):193-200.
PMID: 20809423
Preclinical and clinical studies have demonstrated synergy between bortezomib and pegylated liposomal doxorubicin (PLD) for relapsed/refractory (R/R) multiple myeloma (MM) patients compared to bortezomib as a single agent. This retrospective...